DC-CIK cell therapy (Jinling Hospital)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameDC-CIK cell therapy (Jinling Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell

Mechanisms of ActionDendritic cells modulators

TargetsNot applicable

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesJinling Hospital,Nanjing University,School Medicine

China Registration ClassN/A

Develop Information

Active CompaniesJinling Hospital,Nanjing University,School Medicine

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A